Clinical Trials

Showing trials with last updates posted in 2024.

NCT06287398 | RECRUITING | PHASE2
39 participants

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

Study Type:
INTERVENTIONAL
Last Updated:
2024-07-22
Start Date:
2023-12-11
Completion:
2026-11-30
Conditions
  • DLBCL - Diffuse Large B Cell Lymphoma
  • High-grade B-cell Lymphoma
  • High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • DLBCL, Nos Genetic Subtypes
  • High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Follicular Large Cell Lymphoma, Relapsed
  • Follicular Large Cell Lymphoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page